Xiaogong Li
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Urology top 10%
Papers in
-
- Renal cell carcinoma treatment 34
- Prostate Cancer Diagnosis and Treatment 10
-
- Renal and related cancers 29
- Co-authors
- Hongqian Guo (53 shared papers)Gutian Zhang (32 shared papers)Changwei Ji (25 shared papers)Xiaozhi Zhao (29 shared papers)Weidong Gan (15 shared papers)Weidong Gan (25 shared papers)Huibo Lian (19 shared papers)Linfeng Xu (14 shared papers)
- Journals
- BMC Urology (4 papers)Urology (4 papers)Journal of Endourology (2 papers)Scientific Reports (2 papers)World Journal of Surgical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Xiaogong Li
63 papers receiving 721 citations
Peers
Comparison fields: 5 of 84
- Pulmonary and Respiratory Medicine 514
- Urology 55
- Rheumatology 84
- Cancer Research 76
- Radiology, Nuclear Medicine and Imaging 113
Countries citing papers authored by Xiaogong Li
This map shows the geographic impact of Xiaogong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaogong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaogong Li more than expected).
Fields of papers citing papers by Xiaogong Li
This network shows the impact of papers produced by Xiaogong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaogong Li. The network helps show where Xiaogong Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaogong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 42 | |
| 2 | 2017 | 40 | |
| 3 | 2017 | 39 | |
| 4 | 2011 | 38 | |
| 5 | 2011 | 31 | |
| 6 | 2010 | 31 | |
| 7 | 2016 | 31 | |
| 8 | 2012 | 27 | |
| 9 | 2020 | 20 | |
| 10 | 2012 | 20 | |
| 11 | The association of tea consumption and the risk and progression of prostate cancer: a meta-analysis. | 2014 | 20 |
| 12 | 2012 | 19 | |
| 13 | 2013 | 19 | |
| 14 | 2020 | 19 | |
| 15 | 2016 | 18 | |
| 16 | 2016 | 17 | |
| 17 | 2016 | 16 | |
| 18 | 2017 | 16 | |
| 19 | 2012 | 15 | |
| 20 | 2014 | 14 |
About Xiaogong Li
Xiaogong Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Rheumatology and Pediatrics, Perinatology and Child Health, having authored 68 papers that have together received 729 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (34 papers), Renal and related cancers (29 papers), Bladder and Urothelial Cancer Treatments (13 papers), Prostate Cancer Diagnosis and Treatment (10 papers), Pediatric Urology and Nephrology Studies (7 papers), Urological Disorders and Treatments (7 papers), MRI in cancer diagnosis (6 papers) and Urologic and reproductive health conditions (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (514 citations), Urology (55 citations), Rheumatology (84 citations), Cancer Research (76 citations) and Radiology, Nuclear Medicine and Imaging (113 citations). Xiaogong Li has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Hongqian Guo, Gutian Zhang, Changwei Ji, Xiaozhi Zhao, Weidong Gan, Weidong Gan, Huibo Lian, Linfeng Xu, Shiwei Zhang and Guang‐Xiang Liu. Their work appears in journals such as BMC Urology, Urology, Journal of Endourology, Scientific Reports and World Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.